Crohn’s and colitis awareness week runs from the 1st to the 7th December, this year’s focus is the patient voice and improving quality of life for people affected by Crohn’s and colitis. touchIMMUNOLOGY were delighted to talk with expert faculty member Dr. Gil Y. Melmed (Cedars-Sinai, Los Angeles, CA, USA) around the aims of the Crohn’s and Colitis Awareness Week and how important awareness is in improving patient outcomes and quality of life.
Disclosures: Gil Melmed discloses consulting for Abbvie, Arena, Boehringer-Ingelheim, Bristol-Myers Squibb, Celgene, Janssen, Gilead, Genetech, Pfizer, Samsung Bioepis, Takeda, Shionogi, Prometheus Labs, Techlab, Fresenius Kabi, and Amgen; and receiving grant/ research support from Pfizer.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.
To find out more visit the website here.
